Karydas Daphne

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Karydas Daphne
CIK #0001816952
EDGAR Form CIK 2011 - 2026
3 [0001816952]
4 [0001816952]
Form 3/4/5 Subject 2011 - 2026
Mineralys Therapeutics Inc
Karydas Daphne
COMPASS Pathways PLC
LogicBio Therapeutics Inc
Syndax Pharmaceuticals Inc
Eucrates Biomedical Acquisition Corp
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Mineralys Therapeutics Inc MLYS
Common Stock
2026-02-19 Grant 6,200 $0.00
Mineralys Therapeutics Inc MLYS
Stock Option · derivative
2026-02-19 Grant 8,300 $0.00
Mineralys Therapeutics Inc MLYS
Common Stock
2025-11-13 Option exercise 15,000 $10.20 153,000
Mineralys Therapeutics Inc MLYS
Common Stock
2025-11-13 Sell 4,885 $46.36 226,469
Mineralys Therapeutics Inc MLYS
Stock Option · derivative
2025-11-13 Option exercise 15,000 $0.00
Mineralys Therapeutics Inc MLYS
Common Stock
2025-11-13 Sell 10,115 $45.81 463,368
COMPASS Pathways PLC CMPS
Share Option (Right to Buy) · derivative
2025-06-12 Grant 26,000 $0.00
Mineralys Therapeutics Inc MLYS
Stock Option · derivative
2025-02-13 Grant 32,900 $0.00
Mineralys Therapeutics Inc MLYS
Stock Option · derivative
2024-05-22 Grant 22,000 $0.00
COMPASS Pathways PLC CMPS
Share Option (Right to Buy) · derivative
2024-05-09 Grant 26,000 $0.00
COMPASS Pathways PLC CMPS
Share Option (Right to Buy) · derivative
2023-09-18 Grant 52,000 $0.00
Mineralys Therapeutics Inc MLYS
Stock Option · derivative
2023-09-13 Grant 44,000 $0.00
LogicBio Therapeutics Inc LOGC
Stock Option (right to buy) · derivative
2022-11-16 Disposed to issuer 12,500
LogicBio Therapeutics Inc LOGC
Stock Option (right to buy) · derivative
2022-06-17 Grant 12,500 $0.00
LogicBio Therapeutics Inc LOGC
Stock Option (right to buy) · derivative
2021-06-11 Grant 12,500 $0.00
Syndax Pharmaceuticals Inc SNDX
Stock Option (Right to Buy) · derivative
2021-02-03 Grant 95,000 $0.00
LogicBio Therapeutics Inc LOGC
Stock Option (right to buy) · derivative
2020-12-10 Grant 20,000 $0.00
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com